NR3C1 and cancer: GCR knockdown decreases ROS generation in iB16 cells, and lower ROS levels are associated with a decrease in nuclear Nrf2 in metastatic cells (Fig. 3, Table 1), whereas acute oxidative stress and inflammation (as occurs in organs invaded by cancer) may also be associated with impaired activation of Nrf2 [60].